Intercept Pharmaceuticals

This study tested a drug called obeticholic acid in children with biliary atresia who had a Kasai surgery. The goal was to see if the drug could delay serious liver problems like the need for a transplant or death. The trial was stopped early, and it involved 28 children from bir…

This study tested whether combining two drugs, obeticholic acid and bezafibrate, could improve liver health in people with primary biliary cholangitis (PBC) who did not get enough help from standard treatment. About 75 adults with PBC took part. The goal was to see if the combina…

This study tested a new medicine called INT-787 in people with severe liver inflammation caused by heavy drinking. The goal was to see if the drug could improve liver function and was safe. The trial was stopped early, so results are limited. It involved 67 adults aged 18 to 65 w…

This study looked at the long-term safety of a fixed-dose combination of two drugs, obeticholic acid and bezafibrate, for people with primary biliary cholangitis (PBC), a chronic liver disease. It enrolled 63 adults who had already been taking the combination in earlier studies. …